Lindsay A. Renfro

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

Axel Grothey, Alberto Sobrero, Anthony F. Shields et al. · New England Journal of Medicine · 2018 · 1.1K citations · Full text

Medicine, Oncology, Pharmacology +16

Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial

Julio García‐Aguilar, Lindsay A. Renfro, Oliver S. Chow et al. · The Lancet Oncology · 2015 · 424 citations · Full text

Medicine, Oncology, Surgery +17

^Non-V600<i>BRAF</i> Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer

Jeremy Jones, Lindsay A. Renfro, Humaid O. Al‐Shamsi et al. · Journal of Clinical Oncology · 2017 · 357 citations

Medicine, Molecular Genetics, Oncology +17

Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database

Lindsay A. Renfro, Fotios Loupakis, Richard Adams et al. · Journal of Clinical Oncology · 2015 · 181 citations · Full text

Medicine, Biostatistics, Oncology +10

Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database

Manish A. Shah, Lindsay A. Renfro, Carmen J. Allegra et al. · Journal of Clinical Oncology · 2016 · 165 citations

Medicine, Oncology, Pharmacology +17